Skip to content
Open access · CC-BY via OpenAlex

Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis

Ram Prasad, Michael John Patton, Jason L. Floyd, Cristiano Pedrozo Vieira, Seth Fortmann, Mariana DuPont, Angie Harbour, Chen See Jeremy, Justin Wright, Regina Lamendella, Bruce R. Stevens, Maria B. Grant

International Journal of Molecular Sciences · 2022 · ▲ 78 citations

Abstract

The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) complications. We aimed to investigate whether the analysis of plasma could provide insight into gut barrier dysfunction in patients with COVID-19 infection. Plasma samples of COVID-19 patients (n = 146) and healthy individuals (n = 47) were collected during hospitalization and routine visits. Plasma microbiome was analyzed using 16S rRNA sequencing and gut permeability markers including fatty acid binding protein 2 (FABP2), peptidoglycan (PGN), and lipopolysaccharide (LPS) in both patient cohorts. Plasma samples of both cohorts contained predominately Proteobacteria, Firmicutes, Bacteroides, and Actinobacteria. COVID-19 subjects exhibit significant dysbiosis (p = 0.001) of the plasma microbiome with increased abundance of Actinobacteria spp. (p = 0.0332), decreased abundance of Bacteroides spp. (p = 0.0003), and an increased Firmicutes:Bacteroidetes ratio (p = 0.0003) compared to healthy subjects. The concentration of the plasma gut permeability marker FABP2 (p = 0.0013) and the gut microbial antigens PGN (p < 0.0001) and LPS (p = 0.0049) were significantly elevated in COVID-19 patients compared to healthy subjects. These findings support the notion that the intestine may represent a source for bacteremia and contribute to worsening COVID-19 outcomes. Therapies targeting the gut and prevention of gut barrier defects may represent a strategy to improve outcomes in COVID-19 patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms23169141
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Prasad, R., Patton, M.J., Floyd, J.L., Vieira, C.P., Fortmann, S., DuPont, M., Harbour, A., Jeremy, C.S., Wright, J., Lamendella, R., Stevens, B.R., &amp; Grant, M.B. (2022). Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23169141
Vancouver
Prasad R, Patton MJ, Floyd JL, Vieira CP, Fortmann S, DuPont M, et al. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23169141.
BibTeX
@article{ram2022Plasma, title = {Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis}, author = {Ram Prasad and Michael John Patton and Jason L. Floyd and Cristiano Pedrozo Vieira and Seth Fortmann and Mariana DuPont and Angie Harbour and Chen See Jeremy and Justin Wright and Regina Lamendella and Bruce R. Stevens and Maria B. Grant}, journal = {International Journal of Molecular Sciences}, year = {2022}, doi = {10.3390/ijms23169141}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings